glp-1 and ssri Receptor Agonists in Mood Disorders: A Psychiatric Perspective SSRIs and GLP-1s Together: Safety

Evaluating medication effects outside of clinical trials: new-user designs

Six of the 503B facilities that received warning letters also initiated voluntary recalls of product prior to receipt of the warning letter

However, potential side effects of branded GLP-1s are well-documented and must be disclosed according to FDA regulations

What they rarely anticipate is how dramatically their dreams might change

[(accessed on 15 November 2025)];2010 Available online: 76.Novo Nordisk Inc Saxenda (Liraglutide) Injection for Subcutaneous Use, U.S

Plummer a , b Purpose of review As the use of long-acting glucagon-like peptide-1 (GLP-1) drugs in the community grows rapidly, an increasing number of patients in the ICU will be affected by the preexisting GLP-1 therapy